SKYSTAR BIO-PHARMACEUTICAL CO Operating Cash Flow
SKYSTAR BIO-PHARMACEUTICAL CO reported Operating Cash Flow of -$10.02 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was $917.50K.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$953.95K.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was -$9.98M, a 593.84% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was $12.05M, a 955.92% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for fiscal 2012 was $5.61M.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for fiscal 2011 was -$1.66M, a 121.49% decline from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities for fiscal 2010 was $7.72M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2013-09-30 | $917.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$36.45K derived: sum of 2 quarters · filed 2013-11-14 | -$10.02M 10-Q · filed 2013-11-14 | $2.03M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-06-30 | -$953.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$10.94M 10-Q · filed 2013-08-14 | $1.11M derived: sum of 3 quarters · filed 2013-08-14 | -$2.84M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-03-31 | -$9.98M 10-Q · filed 2013-05-15 | $2.07M derived: sum of 2 quarters · filed 2013-05-15 | -$1.89M derived: sum of 3 quarters · filed 2013-11-14 | -$6.39M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-12-31 | $12.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $8.09M derived: sum of 2 quarters · filed 2013-11-14 | $3.59M derived: sum of 3 quarters · filed 2013-11-14 | $5.61M 10-K · filed 2013-04-01 | ||
| 2012-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$8.46M derived: sum of 2 quarters · filed 2013-11-14 | -$6.44M 10-Q · filed 2013-11-14 | -$6.12M 10-Q · filed 2012-11-14 | -$5.30M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | -$4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.48M 10-Q · filed 2013-08-14 | -$2.16M 10-Q/A · filed 2012-09-13 | -$1.34M derived: sum of 3 quarters · filed 2013-08-14 | -$216.85K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $2.02M 10-Q · filed 2013-05-15 | $3.16M derived: sum of 2 quarters · filed 2013-05-15 | $4.29M derived: sum of 3 quarters · filed 2013-05-15 | $6.65M derived: sum of 4 quarters · filed 2013-05-15 | ||
| 2011-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $2.26M derived: sum of 2 quarters · filed 2013-04-01 | $4.63M derived: sum of 3 quarters · filed 2013-04-01 | -$1.66M 10-K · filed 2013-04-01 | ||
| 2011-09-30 | $1.12M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $3.49M derived: sum of 2 quarters · filed 2012-11-14 | -$2.80M 10-Q · filed 2012-11-14 | $7.48M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $2.37M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | -$3.92M 10-Q/A · filed 2012-09-13 | $6.36M derived: sum of 3 quarters · filed 2012-09-13 | $3.24M derived: sum of 4 quarters · filed 2012-09-13 | ||
| 2011-03-31 | -$6.29M 10-Q · filed 2012-05-15 | $3.99M derived: sum of 2 quarters · filed 2012-05-15 | $878.13K derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $10.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $7.17M derived: sum of 2 quarters · filed 2012-03-30 | $7.72M 10-K · filed 2012-03-30 | |||
| 2010-09-30 | -$3.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$2.56M 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $553.23K 10-Q/A · filed 2011-09-21 |